Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.84 |
| ▸ | NAMPT | P43490 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8394887 | 1.00 | HTT (0.84) | HTTNAMPTTDP1KMT2ASMN1; SMN2 | |
| SCHEMBL9659457 | 1.00 | HTT (0.84) | HTTNAMPTTDP1KMT2ASMN1; SMN2 | |
| SCHEMBL8396561 | 1.00 | HTT (0.84) | HTTNAMPTTDP1KMT2ASMN1; SMN2 | |
| SCHEMBL1753844 | 0.98 | HTT (0.87) | HTTNAMPTTDP1KMT2ASMN1; SMN2 | |
| SCHEMBL5020904 | 0.93 | HTT (0.97) | HTTTDP1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL24176160 | 0.88 | TDP1 (0.65) | HTTNAMPTTDP1KMT2AEPHX1 | |
| SCHEMBL4285086 | 0.88 | TDP1 (0.65) | HTTNAMPTTDP1KMT2AEPHX1 | |
| SCHEMBL28273729 | 0.88 | TDP1 (0.65) | HTTNAMPTTDP1KMT2AEPHX1 | |
| SCHEMBL10739048 | 0.88 | TDP1 (0.65) | HTTNAMPTTDP1KMT2AEPHX1 | |
| SCHEMBL10739485 | 0.88 | TDP1 (0.65) | HTTNAMPTTDP1KMT2AEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1263607-B1 | THERMAL TRANSFER RECORDING SYSTEM HAVING AN AMORPHOUS DYE PHASE | POLAROID CORP (US) | 2004-12-01 | — | — | EP | claimed |
| US-6537410-B2 | Thermal transfer recording system | POLAROID CORPORATION | 2003-03-25 | — | — | US | claimed |
| EP-1263607-A1 | THERMAL TRANSFER RECORDING SYSTEM HAVING AN AMORPHOUS DYE PHASE | POLAROID CORPORATION (US) | 2002-12-11 | — | — | EP | claimed |
| US-20010043239-A1 | Thermal transfer recording system | MOROOD INTERNATIONAL, SPC (SA) | 2001-11-22 | — | — | US | claimed |
| WO-2001056805-A1 | THERMAL TRANSFER RECORDING SYSTEM HAVING AN AMORPHOUS DYE PHASE | POLAROID CORPORATION (US) | 2001-08-09 | — | — | WO | claimed |
| EP-1493593-B1 | Thermal transfer recording system having an amorphous dye phase | POLAROID CORP (US) | 2006-05-31 | — | — | EP | disclosed |
| EP-1493593-A1 | Thermal transfer recording system having an amorphous dye phase | Polaroid Corporation (US) | 2005-01-05 | — | — | EP | disclosed |
| EP-1263607-B1 | THERMAL TRANSFER RECORDING SYSTEM HAVING AN AMORPHOUS DYE PHASE | POLAROID CORP (US) | 2004-12-01 | — | — | EP | disclosed |
| EP-1263607-A1 | THERMAL TRANSFER RECORDING SYSTEM HAVING AN AMORPHOUS DYE PHASE | POLAROID CORPORATION (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001056805-A1 | THERMAL TRANSFER RECORDING SYSTEM HAVING AN AMORPHOUS DYE PHASE | POLAROID CORPORATION (US) | 2001-08-09 | — | — | WO | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |